Endymed (Israel) Today

ENDY Stock   320.00  0.10  0.03%   

Performance

7 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Less than 9

 
High
 
Low
Low
Endymed is trading at 320.00 as of the 1st of February 2025, a 0.03 percent increase since the beginning of the trading day. The stock's open price was 319.9. Endymed has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 2nd of January 2025 and ending today, the 1st of February 2025. Click here to learn more.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.. The company has 13.76 M outstanding shares. More on Endymed

Moving together with Endymed Stock

  0.86LUMI Bank Leumi LePairCorr
  0.86MZTF Mizrahi TefahotPairCorr
  0.87DSCT Israel Discount BankPairCorr
  0.86MGDL Migdal InsurancePairCorr
  0.81FIBIH FIBI HoldingsPairCorr
  0.85FIBI First International BankPairCorr

Moving against Endymed Stock

  0.36KTOV Purple BiotechPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Endymed Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Endymed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Endymed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Vice President - FinanceRami Aviram
Business ConcentrationHealth Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Endymed (ENDY) is traded on Tel Aviv Stock Exchange in Israel and employs 41 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Endymed's market, we take the total number of its shares issued and multiply it by Endymed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Endymed operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 13.76 M outstanding shares. Endymed has accumulated about 5.02 M in cash with 4.63 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39.
Check Endymed Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Endymed is 35.42 Million. Endymed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Endymed Ownership Details

Endymed Risk Profiles

Although Endymed's alpha and beta are two of the key measurements used to evaluate Endymed's performance over the market, the standard measures of volatility play an important role as well.

Endymed Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Endymed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Endymed Corporate Management

Elected by the shareholders, the Endymed's board of directors comprises two types of representatives: Endymed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endymed. The board's role is to monitor Endymed's management team and ensure that shareholders' interests are well served. Endymed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endymed's outside directors are responsible for providing unbiased perspectives on the board's policies.

Other Information on Investing in Endymed Stock

Endymed financial ratios help investors to determine whether Endymed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endymed with respect to the benefits of owning Endymed security.